2021 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2021 ASCO Summary of mNSCLC Trials: IO Efficacy & irAEs, Racial Disparities in Biomarker & Clinical Trial Enrollment, Amivantamab for EGFR-Resistance
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Salgia
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Salgia
15 views
August 20, 2021
Comments 0
Login to view comments.
Click here to Login
San Francisco